Standex (SXI) CFO Trims Stake, Retains 11,323 Shares
Rhea-AI Filing Summary
Standex International (SXI) – Form 4 filing dated 08/07/2025
Chief Financial Officer, Vice President & Treasurer Ademir Sarcevic reported an open-market sale of 3,047 common shares on 08/06/2025. The weighted-average price was $191.7967 per share, with individual trade prices ranging from $191.690 to $191.915. Following the transaction, Sarcevic’s directly held position decreased to 11,323 shares.
- Transaction code: “S” (sale).
- No derivative securities were involved.
- Filing made as a single reporting person; Rule 10b5-1 box not checked.
The sale represents a liquidity event by a senior executive but does not on its face indicate any change to company fundamentals. Investors may weigh the timing—shortly after fiscal year-end—against the executive’s remaining equity stake.
Positive
- Executive retains 11,323 shares, signalling continued alignment with shareholders.
- Sale occurred at an all-time-high price range near $192, indicating management’s confidence in share valuation.
Negative
- CFO liquidated 3,047 shares (≈21% of his direct stake), which can be perceived as a bearish sentiment indicator.
- No Rule 10b5-1 trading plan cited, raising potential concerns about discretionary timing.
Insights
TL;DR: CFO sold 3,047 SXI shares at ~$192; retains 11,323. Insider sale by finance chief mildly bearish but not alarming in size.
The sale is modest—about US$585k—and leaves the CFO with a meaningful ownership position. No derivatives or 10b5-1 plan were disclosed, which can raise questions about opportunistic timing, but there is no accompanying negative news. The transaction equals roughly 21% of Sarcevic’s prior direct holdings and <0.2% of SXI’s float, so market impact should be limited. Still, investors often view executive sales—especially by the CFO—as a cautious signal because the finance head has deep visibility into near-term results. Overall impact: slightly negative sentiment rather than a fundamental red flag.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,047 | $191.7967 | $584K |
Footnotes (1)
- F1. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $191.690 to $191.915, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
FAQ
Were any derivative securities involved in this Form 4?
Was the sale executed under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.